Reduction of infarct size following coronary occlusion

Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group.

Journal of the American College of Cardiology·1992

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

The New England journal of medicine·1992

Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators.

The New England journal of medicine·1992

Mechanisms of early death despite thrombolytic therapy: experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study.

Journal of the American College of Cardiology·1992

Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II.

Circulation·1992

One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial.

Circulation·1992

RNA-Binding Protein MBNL2 Drives Cardiac Hypertrophy and Dysfunction by Facilitating TPM3 Splicing.

Circulation research·2026

Gut Dysbiosis Promotes Myocardial Hypertrophy via GBP2b/GBP1 in Chronic Colitis.

Circulation research·2026

Blood Metabolomic Signatures of 1-Hour Glucose Predict Cardiometabolic Risk.

Circulation research·2026

Hepatic ChREBP Drives Cardiac Remodeling via ApoM Nontranscriptional Repression.

Circulation research·2026

Mitophagy Facilitates Cytosolic Proteostasis to Preserve Cardiac Function.

Circulation research·2026

Regulated HSPG Signaling Directs Epicardial Behavior to Support Cardiac Formation.

Circulation research·2026

Effect of online hemodiafiltration on cardiovascular risk profile in children with end stage kidney disease.

QJM : monthly journal of the Association of Physicians·2026

Impact of Hypertensive Heart Disease on Coronary Artery Disease Severity Assessed by the Duke Coronary Artery Disease Index.

Cureus·2026

Acute myocardial infarction revealing a thrombotic right coronary artery-superior vena cava fistula: a case report.

European heart journal. Case reports·2026

Unsupervised clustering identifies distinct phenotypes in acute myocardial infarction: insights from the FAST-MI 2015 registry.

Frontiers in artificial intelligence·2026

Implications of the 2025 AHA/ACC hypertension guideline on hypertension prevalence, treatment eligibility and blood pressure control in Nigeria: a cross-sectional comparative study.

BMJ public health·2026

Rigid plate fixation versus wire cerclage for sternal closure after coronary artery bypass grafting: a retrospective cohort study.

Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery·2026

Related Experiment Videos

Reduction of infarct size following coronary occlusion

Related Concept Videos

Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group.

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators.

Mechanisms of early death despite thrombolytic therapy: experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study.

Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II.

One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial.

RNA-Binding Protein MBNL2 Drives Cardiac Hypertrophy and Dysfunction by Facilitating TPM3 Splicing.

Gut Dysbiosis Promotes Myocardial Hypertrophy via GBP2b/GBP1 in Chronic Colitis.

Blood Metabolomic Signatures of 1-Hour Glucose Predict Cardiometabolic Risk.

Hepatic ChREBP Drives Cardiac Remodeling via ApoM Nontranscriptional Repression.

Mitophagy Facilitates Cytosolic Proteostasis to Preserve Cardiac Function.

Regulated HSPG Signaling Directs Epicardial Behavior to Support Cardiac Formation.

Effect of online hemodiafiltration on cardiovascular risk profile in children with end stage kidney disease.

Impact of Hypertensive Heart Disease on Coronary Artery Disease Severity Assessed by the Duke Coronary Artery Disease Index.

Acute myocardial infarction revealing a thrombotic right coronary artery-superior vena cava fistula: a case report.

Unsupervised clustering identifies distinct phenotypes in acute myocardial infarction: insights from the FAST-MI 2015 registry.

Implications of the 2025 AHA/ACC hypertension guideline on hypertension prevalence, treatment eligibility and blood pressure control in Nigeria: a cross-sectional comparative study.

Rigid plate fixation versus wire cerclage for sternal closure after coronary artery bypass grafting: a retrospective cohort study.

Related Experiment Videos

Reduction of infarct size following coronary occlusion

Related Concept Videos

Related Articles